Cargando…

Risk Factors for Venous Thromboembolism in 1.3 Million Pregnancies: A Nationwide Prospective Cohort

OBJECTIVE: To quantify risk factors for venous thromboembolism during pregnancy and the puerperal period. DESIGN: In a nationwide prospective cohort study we followed pregnant and puerperal women in Denmark from 1995 to 2009 for venous thromboembolism. Information on risk factors and confounders was...

Descripción completa

Detalles Bibliográficos
Autores principales: Virkus, Rie Adser, Løkkegaard, Ellen, Lidegaard, Øjvind, Langhoff-Roos, Jens, Nielsen, Anne Kristine, Rothman, Kenneth J., Bergholt, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008580/
https://www.ncbi.nlm.nih.gov/pubmed/24788753
http://dx.doi.org/10.1371/journal.pone.0096495
_version_ 1782314481219534848
author Virkus, Rie Adser
Løkkegaard, Ellen
Lidegaard, Øjvind
Langhoff-Roos, Jens
Nielsen, Anne Kristine
Rothman, Kenneth J.
Bergholt, Thomas
author_facet Virkus, Rie Adser
Løkkegaard, Ellen
Lidegaard, Øjvind
Langhoff-Roos, Jens
Nielsen, Anne Kristine
Rothman, Kenneth J.
Bergholt, Thomas
author_sort Virkus, Rie Adser
collection PubMed
description OBJECTIVE: To quantify risk factors for venous thromboembolism during pregnancy and the puerperal period. DESIGN: In a nationwide prospective cohort study we followed pregnant and puerperal women in Denmark from 1995 to 2009 for venous thromboembolism. Information on risk factors and confounders was retrieved from national registries. The diagnosis of venous thromboembolism was confirmed through medical charts. We calculated adjusted incidence rates per 10,000 women years and used Poisson regression to estimate effects during pregnancy and the puerperal period. RESULTS: We studied 1,297,037 pregnancies and related puerperal periods, during which there were 748 venous thromboembolisms. The incidence rate for venous thromboembolism during a pregnancy with and without hospitalization for hyperemesis was 15.2/10,000 yr and 6.3/10,000 yr, respectively, (adjusted rate ratio: 2.5 (95%-confidence interval; 1.4–4.5)). The incidence rate among women with multiple pregnancies was 18.2/10,000 yr and 6.3/10,000 yr in singletons (adjusted rate ratio: 2.8 (1.9–4.2)). Increased risk was found with hospitalization during pregnancy or the puerperal period with incidence rates of 42.1/10.000 and 54.7/10.000, respectively, (rate ratios: 12.2 (8.7–17) and 5.9 (4.0–8.8)). Women hospitalized with infections during pregnancy had incidence rates of 25.9/10,000 yr and 29.3/10,000 yr during pregnancy and the puerperal period, respectively, and of 62.7/10,000 yr if hospitalized with infection in the puerperal period. Puerperal venous thromboembolism was associated with hospitalization for preeclampsia and intrauterine growth restriction/fetal death with incidence rates of 45.8/10,000 yr and 18.3/10,000 yr, respectively (rate ratio: 5.0 (3.1–7.8) and 1.9 (0.9–4.4)). Additionally puerperal venous thromboembolism was associated with obesity, elective and acute caesarean sections and major postpartum bleeding with incidence rates of 25.5/10,000 yr, 23.2/10,000 yr, 34.0/10,000 yr and 20.3/10,000 yr, respectively (rate ratios 1.7 (1.1–2.7), 2.1 (1.4–3.1), 3.0 (2.3–4.0) and 1.4 (1.0–2.1)). CONCLUSIONS: Important risk factors for venous thromboembolism during pregnancy or the puerperal period were hospitalization, infection, hyperemesis, multiple pregnancies, preeclampsia, obesity, caesarean section, major postpartum bleeding, and intrauterine growth restriction or fetal death.
format Online
Article
Text
id pubmed-4008580
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40085802014-05-09 Risk Factors for Venous Thromboembolism in 1.3 Million Pregnancies: A Nationwide Prospective Cohort Virkus, Rie Adser Løkkegaard, Ellen Lidegaard, Øjvind Langhoff-Roos, Jens Nielsen, Anne Kristine Rothman, Kenneth J. Bergholt, Thomas PLoS One Research Article OBJECTIVE: To quantify risk factors for venous thromboembolism during pregnancy and the puerperal period. DESIGN: In a nationwide prospective cohort study we followed pregnant and puerperal women in Denmark from 1995 to 2009 for venous thromboembolism. Information on risk factors and confounders was retrieved from national registries. The diagnosis of venous thromboembolism was confirmed through medical charts. We calculated adjusted incidence rates per 10,000 women years and used Poisson regression to estimate effects during pregnancy and the puerperal period. RESULTS: We studied 1,297,037 pregnancies and related puerperal periods, during which there were 748 venous thromboembolisms. The incidence rate for venous thromboembolism during a pregnancy with and without hospitalization for hyperemesis was 15.2/10,000 yr and 6.3/10,000 yr, respectively, (adjusted rate ratio: 2.5 (95%-confidence interval; 1.4–4.5)). The incidence rate among women with multiple pregnancies was 18.2/10,000 yr and 6.3/10,000 yr in singletons (adjusted rate ratio: 2.8 (1.9–4.2)). Increased risk was found with hospitalization during pregnancy or the puerperal period with incidence rates of 42.1/10.000 and 54.7/10.000, respectively, (rate ratios: 12.2 (8.7–17) and 5.9 (4.0–8.8)). Women hospitalized with infections during pregnancy had incidence rates of 25.9/10,000 yr and 29.3/10,000 yr during pregnancy and the puerperal period, respectively, and of 62.7/10,000 yr if hospitalized with infection in the puerperal period. Puerperal venous thromboembolism was associated with hospitalization for preeclampsia and intrauterine growth restriction/fetal death with incidence rates of 45.8/10,000 yr and 18.3/10,000 yr, respectively (rate ratio: 5.0 (3.1–7.8) and 1.9 (0.9–4.4)). Additionally puerperal venous thromboembolism was associated with obesity, elective and acute caesarean sections and major postpartum bleeding with incidence rates of 25.5/10,000 yr, 23.2/10,000 yr, 34.0/10,000 yr and 20.3/10,000 yr, respectively (rate ratios 1.7 (1.1–2.7), 2.1 (1.4–3.1), 3.0 (2.3–4.0) and 1.4 (1.0–2.1)). CONCLUSIONS: Important risk factors for venous thromboembolism during pregnancy or the puerperal period were hospitalization, infection, hyperemesis, multiple pregnancies, preeclampsia, obesity, caesarean section, major postpartum bleeding, and intrauterine growth restriction or fetal death. Public Library of Science 2014-05-02 /pmc/articles/PMC4008580/ /pubmed/24788753 http://dx.doi.org/10.1371/journal.pone.0096495 Text en © 2014 Virkus et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Virkus, Rie Adser
Løkkegaard, Ellen
Lidegaard, Øjvind
Langhoff-Roos, Jens
Nielsen, Anne Kristine
Rothman, Kenneth J.
Bergholt, Thomas
Risk Factors for Venous Thromboembolism in 1.3 Million Pregnancies: A Nationwide Prospective Cohort
title Risk Factors for Venous Thromboembolism in 1.3 Million Pregnancies: A Nationwide Prospective Cohort
title_full Risk Factors for Venous Thromboembolism in 1.3 Million Pregnancies: A Nationwide Prospective Cohort
title_fullStr Risk Factors for Venous Thromboembolism in 1.3 Million Pregnancies: A Nationwide Prospective Cohort
title_full_unstemmed Risk Factors for Venous Thromboembolism in 1.3 Million Pregnancies: A Nationwide Prospective Cohort
title_short Risk Factors for Venous Thromboembolism in 1.3 Million Pregnancies: A Nationwide Prospective Cohort
title_sort risk factors for venous thromboembolism in 1.3 million pregnancies: a nationwide prospective cohort
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008580/
https://www.ncbi.nlm.nih.gov/pubmed/24788753
http://dx.doi.org/10.1371/journal.pone.0096495
work_keys_str_mv AT virkusrieadser riskfactorsforvenousthromboembolismin13millionpregnanciesanationwideprospectivecohort
AT løkkegaardellen riskfactorsforvenousthromboembolismin13millionpregnanciesanationwideprospectivecohort
AT lidegaardøjvind riskfactorsforvenousthromboembolismin13millionpregnanciesanationwideprospectivecohort
AT langhoffroosjens riskfactorsforvenousthromboembolismin13millionpregnanciesanationwideprospectivecohort
AT nielsenannekristine riskfactorsforvenousthromboembolismin13millionpregnanciesanationwideprospectivecohort
AT rothmankennethj riskfactorsforvenousthromboembolismin13millionpregnanciesanationwideprospectivecohort
AT bergholtthomas riskfactorsforvenousthromboembolismin13millionpregnanciesanationwideprospectivecohort